Analysis of interleukin (IL)-1β IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1305-1308

  Libra, Massimo ^a   Mangano, Katia ^a   Anzaldi, Massimiliano ^a   Quattrocchi, Cinzia ^a   Donia, Marco ^a   Di Marco, Roberto ^a,b   Signorelli, Santo ^a   Scalia, Guido ^a   Zignego, Anna L ^c   De Re, Valli ^d   Mazzarino, Maria C ^a   Nicoletti, Ferdinando ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Interleukin 1; Mixed cryoglobulinemia syndrome; Non Hodgkin's lymphoma

Indexed keywords

IL1RAP PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE II; SIALOGLYCOPROTEIN; VIRUS RNA;

ARTICLE; B CELL LYMPHOMA; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CRYOGLOBULINEMIA; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MONONUCLEAR CELL; VIROLOGY;

CASE-CONTROL STUDIES; CRYOGLOBULINEMIA; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; RNA, VIRAL; SIALOGLYCOPROTEINS;

EID: 33744989717     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1305     Document Type: Article

References (28)

1. Lauer GM and Walker BD: Hepatitis C virus infection. N Engl J Med 345: 41-52, 2001. (Pubitemid 32634271)
2. Silvestri F, Pipan C, Barillari G, et al: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87: 4296-4301, 1996. (Pubitemid 26152271)
3. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M and Levy S: The B-cell receptor of a hepatitis C virus (HCV)- associated non-Hodgkin's lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98: 3745-3749, 2001.
4. Negri E, Little D, Boiocchi M, La Vecchia C and Franceschi S: B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic. Int J Cancer 111: 1-8, 2004. (Pubitemid 38859276)
5. Libra M, Gasparotto D, Gloghini A, Navolanic PM, de Re V and Carbone A: Hepatitis C virus (HCV) infection and lymphoproliferative disorders. Front Biosci 10: 2460-2471, 2005. (Pubitemid 40905250)
6. Andus T, Bauer J and Gerok W: Effects of cytokines on the liver. Hepatology 13: 364-375, 1991.
7. Napoli J, Bishop GA and McCaughan GW: Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology 107: 789-798, 1994. (Pubitemid 24265527)
8. Sims JE and Smith DE: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type II and interleukin-1 receptor accessory protein. Eur Cytokine Netw 14: 77-81, 2003. (Pubitemid 37041320)
9. Onozaki K, Matsushima K, Aggarwal BB and Oppenheim JJ: Human interleukin-1 is a cytocidal factor for several tumor cell lines. J Immunol 135: 3962-3968, 1985. (Pubitemid 16250376)
10. Dinarello CA: Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4: 378-385, 2004.
11. Cominelli F and Pizarro TT: Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 2: 49-53, 1996. (Pubitemid 26341295)
12. Arend WP: Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist. Semin Arthritis Rheum 30: 1-6, 2001.
13. Nicoletti F, Patti F, diMarco R, Zaccone P, Nicoletti A, Meroni P and Reggio A: Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine 8: 395-400, 1996.
14. De Jong BA, Huizinga TW, Bollen EL, et al : Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 126: 172-179, 2002. (Pubitemid 34521742)
15. Chang DM: Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus. Immunol Invest 26: 649-659, 1997.
16. Mandrup-Poulsen T, Pociot F, Molvig J, et al: Monokine antagonism is reduced in patients with IDDM. Diabetes 43: 1242-1247, 1994. (Pubitemid 24361191)
17. Crusius JB, Pena AS, van Oosten BW, et al : Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 346: 979, 1995.
18. Perrier S, Coussediere C, Dubost JJ, Albuisson E and Sauvezie B: IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87: 309-313, 1998. (Pubitemid 28285448)
19. Carter MJ, Jones S, Camp NJ, et al: Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun 5: 8-15, 2004. (Pubitemid 38967624)
20. Gramantieri L, Casali A, Trere D, et al: Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. Clin Exp Immunol 115: 515-520, 1999. (Pubitemid 29130369)
21. Bahr MJ, el Menuawy M, Boeker KH, Musholt PB, Manns MP and Lichtinghagen R: Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C. Liver Int 23: 420-425, 2003. (Pubitemid 37540980)
22. Libra M, Gloghini A, de Re V, et al: Aggressive forms of non- Hodgkin's lymphoma in two patients bearing co-infection of Epstein-Barr and hepatitis C viruses. Int J Oncol 26: 945-950, 2005.
23. Harris NL, Jaffe ES, Diebold J, et al : The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 37: 282-283, 2000.
24. Zignego AL, Ferri C, Giannini C, et al: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 124: 31-34, 1996. (Pubitemid 26019622)
25. Peters M: Actions of cytokines on the immune response and viral interactions: an overview. Hepatology 23: 909-916, 1996.
26. Bronowicki JP, Loriot MA, Thiers V, et al: Hepatitis C virus persistence in human haematopoietic cells injected into SCID mice. Hepatology 28: 211-218, 1998. (Pubitemid 28300003)
27. Cotler SJ, Craft T, Ferris M, et al : Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1. J Interferon Cytokine Res 22: 549-554, 2002. (Pubitemid 34639145)
28. Furst DE: Anakinra: review of recombinant human interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 26: 1960-1975, 2004. (Pubitemid 40353607)